[Intractable Hemorrhagic Duodenal Ulcer after Atezolizumab plus Bevacizumab Treatment for Hepatic Cancer with Lymph Node Metastases-A Case Report]
{{output}}
A 72-year-old woman with liver cirrhosis, diabetes, and parkinsonism was treated with atezolizumab plus bevacizumab (Atezo/Bev)for hepatic cancer and multiple lymph node metastases around the duodenum. After 2 doses of this treatment, alpha-fetoprotein(AFP)lev... ...
